Biomerieux Logo

Procalcitonin: How Procalcitonin Can Help

The complex and aggressive nature of sepsis makes it particularly challenging to manage, and mortality among sepsis patients remains unacceptably high. Second only to heart attack, it is the leading cause of death in the intensive care unit. As many as 750,000 patients progress into severe sepsis each year in U.S. hospitals, and approximately 200,000 of these patients do not survive.1

The need for more effective strategies to help manage sepsis is urgent. Procalcitonin (PCT) is a critical piece of the puzzle, yet the biomarker is underutilized in the United States.

We offer a series of educational webinars led by US experts in Procalcitonin (PCT) focusing on the role of PCT in the diagnosis and management of sepsis.

Sepsis & Procalcitonin Education Webinars

1. Angus DC, Linde-Zwirble WT, Lidicker J, et al. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care. Crit Care Med 2001; 29: 1303-1310.


Watch the inspiring video of sepsis survivor Patricia Cragen and her family as they experience a once in a lifetime event at Strike Out Sepsis Day with the St. Louis Cardinals on August 31, 2015. Watch Video >

See highlights from the Second National Forum on Sepsis, held September 16, 2015 in Washington, DC, and learn more about the Rory Staunton Foundation’s initiatives to raise awareness and knowledge about sepsis. Watch Video >


  • VIDAS® B•R•A•H•M•S PCT™ for the Clinician - Download
  • Procalcitonin: A Novel Biomarker for Bacterial Infections and Sepsis - Download
  • Procalcitonin Over Time - Download
  • Blood Culture: A Key Investigation for Diagnosis of Bloodstream Infections - Download